Global Adrenal Cancer Diagnostics Market Poised for 6.5% Growth, Surpassing $193.26 Billion by 2029
What
are the recent trends in market size and growth for the adrenal cancer
diagnostics market?
The adrenal cancer diagnostics market size has grown strongly in recent years.
It will grow from $140.35 billion in 2024 to $149.96 billion in 2025 at a
compound annual growth rate (CAGR) of 6.8%.
The growth in the historic period can be attributed to increased
incidence and awareness, genetic and molecular testing advances, biopsy
techniques improvement, enhanced endocrine testing, integration of artificial
intelligence (ai).
The adrenal cancer diagnostics market size is expected to see strong growth in
the next few years. It will grow to $193.26 billion in 2029 at a compound
annual growth rate (CAGR) of 6.5%. The
growth in the forecast period can be attributed to personalized medicine
approaches, rise in minimally invasive procedures, telemedicine and remote
consultations, liquid biopsy development, expanded genetic counseling services.
Major trends in the forecast period include regulatory support for diagnostic
innovations, digital pathology adoption, advancements in imaging technologies,
liquid biopsy development, genomic profiling for precision medicine.
Get Your Free Sample of The Global
Adrenal Cancer Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp
How have varous drivers impacted the growth of the adrenal cancer diagnostics
market?
The rising cigarette smoking is expected to propel the growth of the adrenal
cancer diagnostics market going forward. Cigarette smoking refers to the act of
inhaling and exhaling the fumes of burning tobacco, which contains nicotine, an
addictive alkaloid that can have both stimulating and tranquilizing
psychoactive effects. Cigarette smoking has been associated with an increased
risk of adrenal cancer, including adrenal adenomas and adrenocortical
carcinomas. The carcinogens in tobacco smoke can damage the DNA in adrenal
cells, leading to mutations that can cause cancer. For instance, in July 2022,
according to Statistics Canada, a Canada-based government agency, cigarette
production increased by 5.8% compared to June 2021. Additionally, the total
number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June
2022. Therefore, the rising cigarette smoking is driving the growth of the
adrenal cancer diagnostics market.
What are the primary segments of the adrenal cancer diagnostics market?
The adrenal cancer diagnostics market covered in this report is segmented –
1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan,
X-ray, Positron Emission Tomography (PET) Scan, Biopsy
2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer
Therapies, Other Treatments
3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types
4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other
End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI
2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis
CT Scans
3) By X-ray: Standard X-ray Imaging, Specialized X-ray Techniques
4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans,
Standalone PET Scans
5) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical
Biopsy
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report
Which
firms are leading the adrenal cancer diagnostics market?
Major companies operating in the adrenal cancer diagnostics market report are
Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher
Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare
GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare
Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc.,
Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad
Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc.,
Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc.,
NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials,
APC International Ltd., Annon Piezo Technology Co. Limited
How will industry trends affect the trajectory of the adrenal cancer
diagnostics market?
Major companies operating in the adrenal cancer diagnostics market are
developing innovative initiatives with advanced collaboration models, such as
the CancerX Startup Accelerator, to enhance digital innovations in cancer care.
The Accelerator aims to provide promising startups with mentorship, training,
and direct access to key players in the healthcare industry, including
providers and pharmaceutical companies. For instance, in November 2023,
CanceRx, LLC, a US-based public-private partnership to boost innovation in the
fight against cancer, announced the launch of this initiative at the Future of
Cancer Care Summit in Tampa, Florida. The program will select its inaugural cohort
of approximately 15 to 20 companies starting in March 2024, focusing on
critical themes like clinical research, screening, diagnosis, and treatment. It
is expected to significantly advance the goals of the Cancer Moonshot
initiative by addressing unmet needs in cancer care and fostering the
development of effective digital health tools in oncology.
Which geographic trends are shaping the adrenal cancer diagnostics market, and
which region has the highest market share?
North America was the largest region in the adrenal cancer diagnostics market
in 2024. Asia-Pacific is expected to be the fastest-growing region in the
forecast period. The regions covered in the adrenal cancer diagnostics market
report are Asia-Pacific, Western Europe, Eastern Europe, North America, South
America, Middle East, Africa
What Does The Adrenal Cancer Diagnostics Market Report 2025 Offer?
The adrenal cancer diagnostics market research report from The Business
Research Company offers global market size, growth rate, regional shares,
competitor analysis, detailed segments, trends, and opportunities.
Adrenal cancer diagnostics refers to the process of identifying and diagnosing
adrenal cancer, which is cancer that originates in the adrenal glands located
above the kidneys. This process involves a series of medical evaluations,
tests, and procedures designed to determine whether a person has adrenal
cancer. It is essential for effective treatment planning and management.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242
About
The Business Research Company
With
over 15000+ reports from 27 industries covering 60+ geographies, The Business
Research Company has built a reputation for offering comprehensive, data-rich
research and insights. Armed with 1,500,000 datasets, the optimistic
contribution of in-depth secondary research, and unique insights from industry
leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence
platform delivering comprehensive and updated forecasts to support informed
decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter:
https://twitter.com/tbrc_info
Facebook:
https://www.facebook.com/TheBusinessResearchCompany
YouTube:
https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare
Blog: https://healthcareresearchreports.com/
Global
Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment